128 related articles for article (PubMed ID: 30937309)
1. Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B.
Guo H; Zhu B; Li S; Li J; Shen Z; Zheng Y; Zhao W; Tan D; Wu J; Zhang X; Jiang Q; Qi X; Mao R; Yu X; Su Z; Zhang J
Biomed Res Int; 2019; 2019():1621627. PubMed ID: 30937309
[TBL] [Abstract][Full Text] [Related]
2. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
[TBL] [Abstract][Full Text] [Related]
3. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
Wu Z; Dong X; Wang G; Zhao H;
J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
[TBL] [Abstract][Full Text] [Related]
4. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
5. A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.
Chen S; Huang H; Huang W
BMC Gastroenterol; 2021 Jan; 21(1):4. PubMed ID: 33407146
[TBL] [Abstract][Full Text] [Related]
6. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal.
Gao S; Li XY; Fan YC; Sun FK; Han LY; Li F; Ji XF; Wang K
J Gastroenterol Hepatol; 2017 Jan; 32(1):215-220. PubMed ID: 27207016
[TBL] [Abstract][Full Text] [Related]
7. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
[TBL] [Abstract][Full Text] [Related]
8. A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B.
Wang J; Xia J; Zhang R; Yan X; Yang Y; Zhao X; Chang H; Wang G; Chen G; Liu Y; Chen Y; Jia B; Zhang Z; Ding W; Huang R; Wu C
J Viral Hepat; 2018 Oct; 25(10):1151-1160. PubMed ID: 29741221
[TBL] [Abstract][Full Text] [Related]
9. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
[TBL] [Abstract][Full Text] [Related]
10. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
11. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
Zeng X; Xu C; He D; Li M; Zhang H; Wu Q; Xiang D; Wang Y
Croat Med J; 2015 Jun; 56(3):272-9. PubMed ID: 26088852
[TBL] [Abstract][Full Text] [Related]
12. A noninvasive model discriminating significant histological changes in treatment-naive chronic hepatitis B patients with normal ALT.
Teng J; Du Y; Visalath P; Zhou T; Du B; Zhang Q; Cai W
Virol J; 2023 Jan; 20(1):7. PubMed ID: 36631824
[TBL] [Abstract][Full Text] [Related]
13. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection.
Wang JY; Mao RC; Zhang YM; Zhang YJ; Liu HY; Qin YL; Lu MJ; Zhang JM
J Viral Hepat; 2015 Feb; 22(2):128-36. PubMed ID: 25131617
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive models for predicting histology in patients with chronic hepatitis B.
Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
[TBL] [Abstract][Full Text] [Related]
16. Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT.
Wang H; Xue L; Yan R; Zhou Y; Wang MS; Cheng MJ; Hai-Jun Huang
PLoS One; 2013; 8(11):e80585. PubMed ID: 24260428
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
[TBL] [Abstract][Full Text] [Related]
18. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
[TBL] [Abstract][Full Text] [Related]
19. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
[TBL] [Abstract][Full Text] [Related]
20. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
